(Q34413846)

2 August 2017

The role of vitamin D in reducing cancer risk and progression (English)

1 reference

2 August 2017

0 references

0 references

4

Edward Giovannucci

1 reference

2 August 2017

David Feldman

1

1 reference

2 August 2017

Aruna V Krishnan

series ordinal

2

1 reference

2 August 2017

Srilatha Swami

series ordinal

3

1 reference

2 August 2017

Brian J Feldman

series ordinal

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

4 April 2014

1 reference

2 August 2017

Nature Reviews Cancer

1 reference

2 August 2017

14

1 reference

2 August 2017

5

1 reference

2 August 2017

342-357

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3691

2 August 2017

0 references

cites work

Current progress in using vitamin D and its analogs for cancer prevention and treatment

1 reference

Vitamin D and differentiation in cancer

31 March 2020

1 reference

Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.

31 March 2020

1 reference

Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling

31 March 2020

1 reference

The role of vitamin D in cancer prevention and treatment

31 March 2020

1 reference

Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer

31 March 2020

1 reference

Vitamin D and breast cancer: emerging concepts

31 March 2020

1 reference

Vitamin D and colon cancer

31 March 2020

1 reference

The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.

31 March 2020

1 reference

Vitamin D in cutaneous carcinogenesis: part I

31 March 2020

1 reference

The vitamin D receptor in cancer

31 March 2020

1 reference

Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy

31 March 2020

1 reference

Cellular and molecular effects of vitamin D on carcinogenesis

31 March 2020

1 reference

31 March 2020

1 reference

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

31 March 2020

1 reference

Cytochrome P450-mediated metabolism of vitamin D.

31 March 2020

1 reference

Vitamin D 25-hydroxylase - Four decades of searching, are we there yet?

31 March 2020

1 reference

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

31 March 2020

1 reference

Where is the vitamin D receptor?

31 March 2020

1 reference

Vitamin D and human health: lessons from vitamin D receptor null mice.

31 March 2020

1 reference

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

31 March 2020

1 reference

Vitamin D and cancer: a review of molecular mechanisms

31 March 2020

1 reference

Molecular mechanisms of vitamin D action

31 March 2020

1 reference

31 March 2020

1 reference

Vitamin D in chronic kidney disease

31 March 2020

1 reference

Regulation and function of the FGF23/klotho endocrine pathways

31 March 2020

1 reference

Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis

31 March 2020

1 reference

Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase

31 March 2020

1 reference

Regulation of 25-hydroxyvitamin D-1alpha-hydroxylase by epidermal growth factor in prostate cells

31 March 2020

1 reference

Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection

31 March 2020

1 reference

The prostate 25-hydroxyvitamin D-1 alpha-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D.

31 March 2020

1 reference

25-Hydroxyvitamin D-1alpha-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transfer

31 March 2020

1 reference

Randomized Clinical Trial of Vitamin D3 Doses on Prostatic Vitamin D Metabolite Levels and Ki67 Labeling in Prostate Cancer Patients

31 March 2020

1 reference

Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer

31 March 2020

1 reference

Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer.

31 March 2020

1 reference

Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines

31 March 2020

1 reference

Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene

31 March 2020

1 reference

Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer

31 March 2020

1 reference

25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis

31 March 2020

1 reference

Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.

31 March 2020

1 reference

Autocrine metabolism of vitamin D in normal and malignant breast tissue

31 March 2020

1 reference

Vitamin D receptor protein expression in tumor tissue and prostate cancer progression

31 March 2020

1 reference

The association between vitamin D receptor expression and prolonged overall survival in breast cancer.

31 March 2020

1 reference

Regulation of target gene expression by the vitamin D receptor - an update on mechanisms

31 March 2020

1 reference

Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms

31 March 2020

1 reference

Role of the 1,25D3-MARRS receptor in the 1,25(OH)2D3-stimulated uptake of calcium and phosphate in intestinal cells.

31 March 2020

1 reference

The role of the vitamin D receptor and ERp57 in photoprotection by 1α,25-dihydroxyvitamin D3

31 March 2020

1 reference

1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture

31 March 2020

1 reference

Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3

31 March 2020

1 reference

Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment

31 March 2020

1 reference

Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells.

31 March 2020

1 reference

Identification of novel mediators of Vitamin D signaling and 1,25(OH)2D3 resistance in mammary cells

31 March 2020

1 reference

Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays

31 March 2020

1 reference

Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer

31 March 2020

1 reference

Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells

31 March 2020

1 reference

Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis

31 March 2020

1 reference

Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray

31 March 2020

1 reference

SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications

31 March 2020

1 reference

Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy

31 March 2020

1 reference

Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo

31 March 2020

1 reference

Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells

31 March 2020

1 reference

Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells.

31 March 2020

1 reference

Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements

31 March 2020

1 reference

The development of androgen-independent prostate cancer

31 March 2020

1 reference

Molecular pathogenesis and progression of prostate cancer

31 March 2020

1 reference

Androgen receptors in hormone-dependent and castration-resistant prostate cancer

31 March 2020

1 reference

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

31 March 2020

1 reference

Regulation of growth, PSA/PAP and androgen receptor expression by 1 alpha,25-dihydroxyvitamin D3 in the androgen-dependent LNCaP cells

31 March 2020

1 reference

Vitamin D and prostate cancer

31 March 2020

1 reference

Androgen receptor signaling and vitamin D receptor action in prostate cancer cells

31 March 2020

1 reference

Generation of a prostate from a single adult stem cell

31 March 2020

1 reference

Prospective identification of tumorigenic prostate cancer stem cells

31 March 2020

1 reference

Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo

31 March 2020

1 reference

A luminal epithelial stem cell that is a cell of origin for prostate cancer

31 March 2020

1 reference

Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.

31 March 2020

1 reference

Down-regulation of vitamin D receptor in mammospheres: implications for vitamin D resistance in breast cancer and potential for combination therapy

31 March 2020

1 reference

A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer

31 March 2020

1 reference

The long and short of microRNA.

31 March 2020

1 reference

Butyrate and vitamin D3 induce transcriptional attenuation at the cyclin D1 locus in colonic carcinoma cells

31 March 2020

1 reference

MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.

31 March 2020

1 reference

Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue

31 March 2020

1 reference

MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.

31 March 2020

1 reference

1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498.

31 March 2020

1 reference

MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice

31 March 2020

1 reference

Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D

31 March 2020

1 reference

MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3

31 March 2020

1 reference

Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b

31 March 2020

1 reference

MicroRNA regulates human vitamin D receptor

31 March 2020

1 reference

Vitamin D(3) receptor ablation sensitizes skin to chemically induced tumorigenesis

31 March 2020

1 reference

Prevention of preneoplastic lesions by dietary vitamin D in a mouse model of colorectal carcinogenesis

31 March 2020

1 reference

Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer

31 March 2020

1 reference

Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate.

31 March 2020

1 reference

Do sunlight and vitamin D reduce the likelihood of colon cancer?

31 March 2020

1 reference

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

31 March 2020

1 reference

Vitamin D With or Without Calcium Supplementation for Prevention of Cancer and Fractures: An Updated Meta-analysis for the U.S. Preventive Services Task Force

31 March 2020

1 reference

Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies

31 March 2020

1 reference

Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis.

31 March 2020

1 reference

Vitamin D, PTH, and calcium and the risk of prostate cancer: a prospective nested case-control study

31 March 2020

1 reference

Calcium plus vitamin D supplementation and the risk of breast cancer

31 March 2020

1 reference

Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies

31 March 2020

1 reference

Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study

31 March 2020

1 reference

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study

31 March 2020

1 reference

Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

31 March 2020

1 reference

Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

31 March 2020

1 reference

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

31 March 2020

1 reference

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer

31 March 2020

1 reference

Vitamin D status and ill health: a systematic review

31 March 2020

1 reference

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

31 March 2020

1 reference

Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer

31 March 2020

1 reference

Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations

31 March 2020

1 reference

Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis

31 March 2020

1 reference

Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis

31 March 2020

1 reference

Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk

31 March 2020

1 reference

Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk

31 March 2020

1 reference

Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review

31 March 2020

1 reference

31 March 2020

1 reference

31 March 2020

1 reference

31 March 2020

1 reference

Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women

31 March 2020

1 reference

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer

31 March 2020

1 reference

Vitamin D pathway gene variants and prostate cancer risk

31 March 2020

1 reference

Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry

31 March 2020

1 reference

31 March 2020

1 reference

The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease

31 March 2020

1 reference

Uncertain verdict as vitamin D goes on trial

31 March 2020

1 reference

The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial

31 March 2020

1 reference

Vitamin D supplementation in young White and African American women.

31 March 2020

1 reference

Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.

31 March 2020

1 reference

Caution in reinterpreting the Women's Health Initiative (WHI) Calcium and Vitamin D Trial breast cancer results

31 March 2020

1 reference

Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial

31 March 2020

1 reference

Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial

31 March 2020

1 reference

A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/β-catenin pathway in the normal mucosa of colorectal adenoma patients

31 March 2020

1 reference

Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials

31 March 2020

1 reference

Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance

31 March 2020

1 reference

25-Hydroxyvitamin D Levels and Risk of Ischemic Heart Disease, Myocardial Infarction, and Early Death: Population-Based Study and Meta-Analyses of 18 and 17 Studies

31 March 2020

1 reference

Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial).

31 March 2020

1 reference

Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators

31 March 2020

1 reference

Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer

31 March 2020

1 reference

Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer

31 March 2020

1 reference

Feasibility of a randomized controlled trial of vitamin D vs. placebo in women with recently diagnosed breast cancer

31 March 2020

1 reference

Vitamin D pathway gene variants and prostate cancer prognosis

31 March 2020

1 reference

IOM committee members respond to Endocrine Society vitamin D guideline

31 March 2020

1 reference

1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1

31 March 2020

1 reference

Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition

31 March 2020

1 reference

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

31 March 2020

1 reference

1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells

31 March 2020

1 reference

Vitamin D regulates the phenotype of human breast cancer cells.

31 March 2020

1 reference

Cancer-related inflammation

31 March 2020

1 reference

Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells

31 March 2020

1 reference

Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.

31 March 2020

1 reference

1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis.

31 March 2020

1 reference

Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels

31 March 2020

1 reference

Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3.

31 March 2020

1 reference

1,25-Dihydroxyvitamin D3 inhibits tenascin-C expression in mammary epithelial cells

31 March 2020

1 reference

1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration

31 March 2020

1 reference

1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases.

31 March 2020

1 reference

Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin

31 March 2020

1 reference

1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells

31 March 2020

1 reference

Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo

31 March 2020

1 reference

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

31 March 2020

1 reference

Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in ontario, Canada

31 March 2020

1 reference

Vitamin D-binding protein and vitamin D status of black Americans and white Americans

31 March 2020

1 reference

Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies

31 March 2020

1 reference

Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis

31 March 2020

1 reference

Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study

31 March 2020

1 reference

Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of Vitamin D intake mediated through VDR binding

31 March 2020

1 reference

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium

31 March 2020

1 reference

A phase II trial of calcitriol and naproxen in recurrent prostate cancer.

31 March 2020

1 reference

12 December 2020

Effect of dietary vitamin D and calcium on the growth of androgen-insensitive human prostate tumor in a murine model.

1 reference

12 December 2020

Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.

1 reference

12 December 2020

1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells

1 reference

12 December 2020

Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity

1 reference

12 December 2020

Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2

1 reference

12 December 2020

Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1

1 reference

12 December 2020

Vitamin D in cutaneous carcinogenesis: part II.

1 reference

12 December 2020

Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines

1 reference

12 December 2020

Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition

1 reference

12 December 2020

5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells

1 reference

12 December 2020

Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis

1 reference

12 December 2020

Targeted disruption of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in ras-transformed keratinocytes demonstrates that locally produced 1alpha,25-dihydroxyvitamin D3 suppresses growth and induces differentiation in an autocrine fashion

1 reference

12 December 2020

Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)

1 reference

12 December 2020

Induction of androgen receptor by 1alpha,25-dihydroxyvitamin D3 and 9-cis retinoic acid in LNCaP human prostate cancer cells

1 reference

12 December 2020

1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms

1 reference

12 December 2020

Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery

1 reference

12 December 2020

Preclinical activity of ketoconazole in combination with calcitriol or the vitamin D analogue EB 1089 in prostate cancer cells

1 reference

12 December 2020

Calcitriol in the treatment of prostate cancer

1 reference

12 December 2020

Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1.

1 reference

12 December 2020

1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse.

1 reference

12 December 2020

Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity

1 reference

12 December 2020

Ecological studies of the UVB-vitamin D-cancer hypothesis.

1 reference

12 December 2020

Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor

1 reference

12 December 2020

The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature

1 reference

12 December 2020

1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3691

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference